Top Markets
Coin of the day
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc.

AOBI
Xếp hạng trong cổ phiếu #42790
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China,... American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis. Another significant prescription product is the Cease Enuresis Soft Gel (CE Gel brand), formulated to alleviate bedwetting. AOBI's portfolio also extends to various over-the-counter (OTC) pharmaceutical solutions. These feature the Cease Enuresis Patch for managing bedwetting and urinary incontinence; Jinji Capsule, used for conditions like endometritis, annexitis, and pelvic inflammations; Jinji Yimucao, designed to relieve premenstrual syndrome (PMS) and other related menstrual and menopausal discomforts; and Boke Nasal Spray, which offers relief for sinus congestion associated with the common cold, nasal stuffiness, chronic rhinitis, allergic rhinitis, and nasosinusitis. Furthermore, the company develops and markets a selection of nutraceutical products, notably including soybean peptide-based items available as beverages, tablets, powders, and instant coffee. Beyond its manufacturing activities, AOBI is also involved in the wholesale and retail distribution of both its pharmaceutical and nutraceutical goods. The company's products are sold across the People's Republic of China through both direct channels and a network of distributors, reaching hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical retailers, and various other retail outlets.
Giá cổ phiếu
$0.0012
Đồng bộ lần cuối: 2026-08-11
Vốn hóa thị trường
$88.00
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
140.00%
Quốc gia
CN
Giao dịch American Oriental Bioengineering, Inc. (AOBI)

Danh mục

Lịch sử giá cổ phiếu của American Oriental Bioengineering, Inc. (AOBI)
Giá đóng cửa cao nhất: $0.00 vào 2026-08-01

Giá đóng cửa thấp nhất: $535.69 vào 2001-12-01
Lịch sử giá cổ phiếu của American Oriental Bioengineering, Inc. từ 2001 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) 0.00%
2025 140.00%
2024 13.33%
2023 120.59%
2022 -99.99%
2021 15,357.61%
2020 -99.61%
2019 371.70%
2018 -76.13%
2017 -79.44%
2016 107.11%
2015 -21.80%
2014 -72.19%
2013 -87.40%
2012 22.03%
2011 -72.66%
2010 -45.99%
2009 -30.02%
2008 -46.92%
2007 -3.63%
2006 161.57%
2005 187.09%
2004 -54.09%
2003 984.09%
2002 -85.26%
2001 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR